Jose Alvarez Joins Flourish Research as Chief Operating Officer
NEW YORK (PRWEB) June 29, 2023 -- Flourish Research, a leading clinical trial company, is pleased to announce the addition of Jose Alvarez as Chief Operating Officer, overseeing the company’s business operations while supporting Flourish’s vision of continued growth and advancement. He joins the company in the midst of rapid expansion, with operations growing to 12 research sites across six states.
Mr. Alvarez has 20 years of extensive experience in operations and finance within private-equity-owned early-stage and emerging companies. He has a breadth of experience in building new capabilities and scaling operations to enable rapid growth. Most recently he held the role of Chief Operating & Development Officer for Acorn Health, one of the country’s largest providers of autism treatment for children, with over 70 centers spread across 8 states. Mr. Alvarez has also held several other executive roles, including Chief Financial and Strategy officer for several organizations in different sectors.
“I look forward to joining this amazing mission-driven team and sharing my experiences building and developing fast-growing organizations. With a clear focus on quality oversight and an increased focus on operational excellence, Flourish will continue to remain a national leader in the clinical trial space for a long time,” said Mr. Alvarez. “I’m excited to be part of such a rapidly expanding organization and work with some of the most progressive players in the industry.”
“We are truly fortunate to welcome an outstanding executive with such an impressive track record,” said Reinhold Schulz, Chief Executive Officer of Flourish Research. “Jose is a wonderful addition to our leadership team, bringing with him a finely tuned skill set of operational and financial excellence.”
About Flourish Research
Flourish Research is a diversified clinical trial company designed to acquire, operate, and integrate best-in-class clinical research sites with expertise in studies spanning Phases I-IV. Flourish was founded to address the highly fragmented clinical trial site market and provides sponsors and CROs with increased speed and efficiency across a variety of therapeutic areas and indications, while offering a single point of entry to multiple sites. Flourish currently has locations in Florida, Illinois, Pennsylvania, Alabama, North Carolina and Texas. For additional information on Flourish, visit https://flourishresearch.com/
Cindi Heckmann, Flourish Research, http://FlourishResearch.com, 1 2108541614, [email protected]
Share this article